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PERSPECTIVE
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Abstract
Purpose To describe the favorable procedural profile of CT colonography (CTC) during the COVID-19 pandemic.
Conclusion Postponement of cancer screening due to COVID-19 has resulted in a backlog of individuals needing to undergo
structural examination of the colon. The experience during the initial COVID-19 surge with urgent evaluation of the colon
for transplant patients prior to transplant suggests that CTC can be done in a lower risk manner as compared to other structural examinations. The procedural profile of CTC is advantageous during this pandemic as maintaining social distancing
and preserving healthcare supplies including PPE are of paramount importance. CTC is an important option to utilize in
the screening armamentarium to allow effective screening of average risk asymptomatic individuals in the COVID-19 era.
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Introduction
One of the many unavoidable but potentially life-altering
consequences of the current COVID-19 pandemic is the
postponement of cancer screening. Colorectal cancer
screening has dropped 86% during the pandemic relative to
averages prior to January 20, 2020, according to data from
the Epic Health Research Network [1]. Guidance from the
Centers for Disease Control and Prevention and directives
from state officials resulted in the postponement of elective
procedures including cancer screening at facilities to prevent
community spread and to preserve the healthcare workforce,
facilities, and personal protective equipment (PPE) for an
anticipated surge of COVID-19 patients [2]. Additionally,
the American Cancer Society recommended that individuals should not go to a health care facility for routine cancer
screening at the beginning of the pandemic in the USA [3].
As the pandemic has evolved, concerns to handle the surge
have eased and a phased reopening has begun in some states
with the Centers for Medicare and Medicaid Services noting
that “it is important to restart care that is currently being
postponed, such as certain procedural care…, chronic disease care, and, ultimately preventive care” [4]. In regions
and facilities meeting recommendations for resuming care
including adequate facilities, testing, supplies, and workforce, a large backlog of screening exams is anticipated.
Based on currently available information, the USA may
not experience a return to a pre-COVID-19 “normal” until
an effective vaccine and/or treatment for COVID-19 is available or enough Americans have been exposed to COVID19 such that population level herd immunity develops. It is
difficult to estimate when those gating conditions will arise,
though as one example, estimates for the scaled roll-out
of an effective vaccine are generally on the order of many
months to years from the present. In the meantime, the new
normal will likely include continued social distancing, contact tracing, and aggressive testing with fluctuating levels
of new positive COVID-19 patients including a possible reemergence in the fall/winter of 2020 [5]. Thus, the initial
reasons and issues raised by the surge to delay screening
remain to a large extent. This paper highlights the experience
during the surge and potential solutions to mitigate risk as
screening resumes in the upcoming months.

CTC during COVID‑19 pandemic
CT colonography (CTC) for colorectal cancer screening has
typically been canceled and deferred to a later date during
the initial COVID-19 surge as highlighted by an internal
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survey of the American College of Radiology’s Colon Cancer Committee. All committee members noted that elective
CTC screening had ceased at their institutions. The screening situation by CTC mirrors the experience at screening
colonoscopy where similar guidance from the American
Society of Gastrointestinal Endoscopy suggested that all
elective procedures including screening and surveillance
colonoscopy in asymptomatic patients be delayed during
the current pandemic [6].
CTC, however, has continued to be undertaken as an
urgent or semi-urgent test during this time period. Among
diagnostic indications, the one main clinical scenario
involves screening of patients for colorectal cancer prior
to solid organ transplants. This is a primary indication for
CTC undertaken during this time at the University of Texas
Southwestern Medical Center (Dallas, Texas), Duke University Medical Center (Durham, North Carolina), and The
University of Chicago Medical Center (Chicago, Illinois).
Here, CTC has been undertaken as a preferred lower risk
alternative to optical colonoscopy, allowing for effective
assessment and exclusion of significant polyps and cancers
prior to transplant without some of the issues associated
with colonoscopy.

CTC’s favorable procedural profile
during the COVID‑19 pandemic
The procedural profile of CTC as a structural examination
of the colon is favorable in the COVID-19 era where social
distancing and preservation of PPE are prioritized to lessen
community spread and preserve medical supplies given
the likelihood of a second wave (Table 1). CTC images are
acquired by a single healthcare worker (typically a CT technologist) who is briefly in close proximity to the patient
while inserting a small flexible catheter a short distance into
the rectum. The CT technologist can monitor colonic insufflation while standing > 6 feet away from the patient and
then moves to the CT control room for the remainder of the
procedure thus maintaining social distancing. CTC is performed with disposable equipment, the filter on CTC catheters prevents contamination of the insufflator, and technologists have minimal contact with stool when disposing of the
tubing at the conclusion of the examination. SARS-CoV-2
viral RNA has been detected in stool samples of patients
with COVID-19 infection [7, 8]. Although the risk of spread
by fecal aerosolization is unknown, use of appropriate PPE
as per institutional policies for possible aerosol generating
procedures (example, N95 mask) is suggested to reduce the
risk of healthcare worker infection.
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By comparison, optical colonoscopy utilizes more pieces
of PPE as it requires more healthcare workers in close proximity to the patient for longer periods of time including the
endoscopist and additional healthcare workers such as an
anesthesiologist or nurse anesthetist to administer sedation
and a nurse to provide procedural and post-procedural monitoring as the patient recovers from sedation. A healthcare
worker such as a nurse is also required to place an intravenous line prior to the colonoscopy.
As sedation is not utilized for CT colonography, at the
conclusion of the exam (which typically lasts approximately
15–20 min) the patient can exit the radiology department
and drive home without need for post-procedural recovery
from sedation within a healthcare facility. This results in
a very reduced “dwell time” in the imaging facility which
contributes to the goal of achieving limited exposure to other
people and environments. Some outpatient radiology practices are implementing workflows where patients are able
to wait in their car, walk directly from their car to the CT
suite upon notification that it is their time to be imaged, and
then directly to their car following the completion of the
procedure thereby maintaining social distancing and minimizing contact with other patients and healthcare workers.
Additionally, the lack of sedation also limits exposure to a
family member or friend who would otherwise be needed
to drive a patient recovering from sedation home further
maximizing social distancing.
Furthermore, the risk of perforation during screening CTC is significantly lower than optical colonoscopy
(0.0019%) with most patients not requiring surgery [9].
By comparison, the perforation rate during screening optical colonoscopy without polypectomy is 0.056% and is
0.062–0.082% for colonoscopy overall [10, 11]. Though
undesirable at any time, a screening procedure-associated
perforation is especially undesirable in the COVID-19 era
as it would result in unnecessary hospitalization, utilization
of healthcare resources, and potential patient exposure to
hospitalized COVID-19 patients. In addition to the risks of
perforation, the overall hospitalization rate following colonoscopy is 1.6% within the first 7 days and 2.4-3.8% within
30 days following the procedure [12].
The referral rate from CTC to optical colonoscopy is
7.9–13.9%, so for > 85% of patients, screening ends with a
negative CTC exam [13, 14]. A repeat screening CTC exam
in 5 years is recommended for patients with a normal exam
[15].
Although stool-based tests such as multitarget stool DNA
tests (e.g., Cologuard (Exact Sciences, Madison, Wisconsin)) do not require that the patient travel to a healthcare
facility, the ability of stool DNA tests to detect precancerous lesions is lower than optical colonoscopy and CTC. In a
study of 9989 patients who underwent optical colonoscopy,
multitarget stool DNA tests detected 92.3% of cancers but

only 42.4% of advanced precancerous lesions (defined as
lesions including advanced adenomas and sessile serrated
polyps measuring 1 cm or more), and 17.2% of nonadvanced
adenomas [16]. Additionally, CTC can better triage patients
as compared to stool-based tests for polypectomy or surveillance depending on the lesions found. CTC identifies
the size and location of lesions, so if just diminutive/small
polyp(s) are found during pandemic times, the patient may
elect to undergo an interval 2- to 3-year follow-up with CTC
or optical colonoscopy based on age, co-morbidities, and
symptoms. By comparison, patients with a positive stoolbased test typically proceed to optical colonoscopy. The
false positive rate of fecal DNA testing is 10.2–13.4% [16].

CTC availability and accessibility
Insurance claims data and data from the American College
of Radiology’s My CT Colonography locator tool indicate
that CTC is available across the USA though utilization is
variable and generally low [17, 18]. As part of the Affordable Care Act of 2010, commercial insurance plans created
on or after September 23, 2010, are required to cover screening CTC without cost-sharing by the patient (no deductible,
no copayment) based on CTCs A grade from the US Preventive Services Task Force [19, 20]. Medicare currently does
not cover CTC for a screening indication but does cover
CTC for some diagnostic indications. CTC is less costly than
colonoscopy for colorectal cancer screening of commercially
insured patients at the population level [21]. As screening
CTC is performed without intravenous contrast material, it
can be performed at imaging centers without need for onsite contrast coverage as there is no risk of allergic reaction
during the procedure.
Individuals looking for a location that performs CTC in
their area can utilize the American College of Radiology’s
My CT Colonography locator tool [18]. This freely available
web site allows the end user to enter his/her address or zip
code, and institutions performing CTC nearby are displayed.
Institutions performing CTC can add their site(s) to this tool
at no charge by registering via a brief web form and entering
information including site address and phone number.

Gastrointestinal manifestations
of COVID‑19, implications for CTC screening
Although symptoms caused by COVID-19 are most often
respiratory, patients may also develop gastrointestinal
symptoms. The first known case of COVID-19 reported in
the USA presented with a persistent dry cough and 2-day
history of nausea and vomiting, and both respiratory and
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Table 1  Usefulness of CT Colonography (CTC) during the COVID-19 Pandemic
1. Similar to optical colonoscopy, CTC is a structural preventative exam and can see the entire colon.
2. CTC has a lower risk of colon complications such as perforation as compared to optical colonoscopy with lower likelihood of requiring
an inpatient bed during the pandemic.
3. CTC is performed without sedation so there is no need for another person to accompany or drive the patient to the imaging center thus
promoting social distancing.
4. No risk of an adverse reaction to anesthetic with resultant need for hospitalization during the pandemic and sedative medications are
preserved for other patients.
5. CTC is easily scheduled as an early morning appointment for vulnerable patients.
6. Curbside check-in is available to decrease time in a waiting room at some imaging centers.
7. Shorter procedural time (15-20 min), with no need for pre-procedure IV placement or post-procedure monitoring reduces time in a
healthcare facility.
8. Less direct contact with fewer health care workers (e.g., one CT technologist and/or one radiologist is intermittently in the CT suite during the exam).
9. Decreased need for personal protective compared to optical colonoscopy as more healthcare workers are required for optical colonoscopy (e.g., endoscopist, anesthesiologist or nurse anesthetist, nurse(s) for IV placement and procedural and post-procedural monitoring).
10. CTC can better triage patients for polypectomy or surveillance depending on lesions found as compared to stool-based tests and can
better detect precancerous lesions as compared to stool-based tests.

stool specimens tested positive for COVID-19 with rRTPCR testing [8]. In a meta-analysis, 17.6% of patients with
COVID-19 had gastrointestinal symptoms, and COVID-19
viral DNA was detected in stool samples in 38.5% of patients
with diarrhea and 8.7% of patients without diarrhea [22].
COVID-19 has also been found to linger in stool longer than
in respiratory or serum samples, a median of 22 days in
one study [7]. COVID-19 is thought to enter host cells via
cell receptor angiotensin converting enzyme II (ACE2) [23].
ACE2 is highly expressed in lung cells as well as those in
the esophagus, ileum, and colon which may account for its
gastrointestinal manifestations [23, 24].
Symptomatic acute colitis is a relative contraindication to
performing CTC [25]. As abdominal pain and diarrhea can
be symptoms of COVID-19, screening CTC should not be
performed in symptomatic patients. Some institutions may
require a negative COVID-19 test prior to CTC performance.
Although elective screening CTC should not be performed
in patients thought to be infected with COVID-19, it is
known that many patients with COVID-19 are asymptomatic
and the presence of characteristic nodular, peripheral ground
glass opacities with a lower lobe predominance in the lung
bases at CTC could indicate a viral pneumonia, possibly
caused by SARS-CoV2 and necessitates appropriate communication with the referring provider [26].
Whether or not fecal transmission of COVID-19 occurs
is unknown. Current guidance from the Centers for Disease
Control and Prevention states that “there has not been any
confirmed report of virus spreading from feces to a person”,
and the risk of fecal transmission is thought to be low based
on data from previous disease outbreaks caused by other
related coronaviruses including Middle East respiratory
syndrome (MERS) and severe acute respiratory syndrome
(SARS) [27]. As CTC is a theoretical aerosol generating
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procedure (along with esophagrams, upper GI fluoroscopic
studies, and contrast enemas), until more is known about
fecal transmission, CTC should be performed with PPE as
recommended by institutional guidelines for potential aerosol generating procedures [28].

Conclusion
Postponement of cancer screening due to COVID-19 has
resulted in a backlog of individuals needing to undergo
structural examination of the colon. The experience during
the initial surge with urgent evaluation of the colon for transplant patients prior to transplant suggests that CTC can be
done in a lower risk manner. The procedural profile of CTC
is advantageous during this pandemic as maintaining social
distancing and preserving healthcare supplies including PPE
are of paramount importance. CTC is an important option
to utilize in the screening armamentarium to allow effective
screening of average risk asymptomatic individuals in the
COVID-19 era.
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